The Estonian Genome Project in the context of European genome research;Das Estnische Genomprojekt im kontext der Europäischen genomforschung

Deutsche Medizinische Wochenschrift

Volumn 129, Issue SUPPL. 1, 2004, Pages

  Metspalu, A ^a,c   Kohler F ^b   Laschinski, G ^b   Ganten, D ^b   Roots, I ^b  

^a UNIVERSITY OF TARTU   (Estonia)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c UNIVERSITY OF TARTU   (Estonia)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CLOMIPRAMINE; DESIPRAMINE; DOXEPIN; HYDROCHLOROTHIAZIDE; IMIPRAMINE; MAPROTILINE; MIANSERIN; OMEPRAZOLE; PAROXETINE; PROTON PUMP INHIBITOR; TRIMIPRAMINE; VENLAFAXINE;

BIOTECHNOLOGY; CLINICAL RESEARCH; EDUCATION; ESTONIA; ETHICS; EUROPE; GENBANK; GENE POOL; GENOME; GENOTYPE; HUMAN; INDUCED ABORTION; MEDICINE; PHENOTYPE; PILOT STUDY; POPULATION GENETICS; PUBLIC HEALTH; REVIEW; TECHNOLOGY;

DATABASES, NUCLEIC ACID; ESTONIA; GENE POOL; GENE THERAPY; GENETIC RESEARCH; GENOTYPE; HEALTH POLICY; HUMAN GENOME PROJECT; HUMANS; PHENOTYPE; PILOT PROJECTS;

EID: 2342505689     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-824840     Document Type: Review

References (17)

1. Aynacioglu AS, Nacak M, Filiz A, Ekinci E, Roots I. Protective role of glutathione S-transferase P1 (GSTP1) Val105Val genotype in patients with bronchial asthma. Br J Clin Pharmacol 2004; 57: 213-217
2. Brockmöller J, Cascorbi I, Henning S, Meisel C, Roots I. Molecular genetics of cancer susceptibility. Pharmacology 2000; 61: 212-227
3. Collins FS, Green ED, Guttmacher AE, Guyer MS. A vision for the future of genomics research. Nature 2003; 422: 835-847
4. Conney AH. Tailoring cancer chemoprevention regimens to the individual. J Cell Biochem 2004; 97: 277-286
5. Cusi D, Barlassania C, Azzani T, Casari G, Citterio L, Devoto M, Glorioso N, Lanzani C, Manunta P, Righetti M, Rivera R, Stella P, Troffa C, Zagato L, Bianchi G. Polymorphisms of alpha-adducin and salt sensitivity in patients with essential hypertension. Lancet 1997; 349: 1353-1357
6. Dawson E, Abecasis GR, Bumpstead S, Chen Y, Hunt S, Beare DM, Pabial J, Dibling T, Tinsley E, Kirby S, Carter D, Papaspyridonos M, Livingstone S, Ganske A, Rice K, Deloukas P, Mott R, Metspalu A, Bentley DR, Cardon LR, Dunham I. A first-generation linkage disequilibrium map of human chromosome 22. Nature 2002; 418: 544-548
7. Estonian Genome Project Foundation http://www.geenivaramu.ee.
8. Freimer N, Sabatti C. The human phenome project. Nature Genetics 2003; 34: 15-21
9. Gasparini P, Rabionet R, Barbujani G, Melchionda S, Petersen M, Brondum-Nielsen K, Metspalu A, Oitmaa E, Pisano M, Fortina P, Zelante L, Estivill X. High carrier frequency of the 35delG deafness mutation in European populations. Genetic Analysis Consortium of GJB2 35delG. Eur J Hum Genet 2000; 8: 19-23
10. Gong M, Zhang H, Schulz H, Lee YA, Sun K, Bähring S, Luft FC, Nürnberg P, Reis A, Rohde K, Ganten D, Hui R, Hübner N. Genome-wide linkage reveals a locus for human essential (primary) hypertension on chromosome 12p. Human Molecular Genetics 2003; 12: 1273-1277
11. Kaiser J. BIOBANKS: Population databases boom, from Iceland to the US. Science 2002; 298: 1158-1161
12. Katzov H, Chalmers K, Palmgren J, Andreasen N, Johansson B, Cairns NJ, Gatz M, Wilcock GK, Love S, Pedersen NL, Brookes AJ, Blennow K, Kehoe PG, Prince JA. Genetic variants of ABCA1 modify Alzheimer disease risk and quantitative traits related to β-amyloid metabolism. Human Mutation 2004; 23: 358-367
13. Kirchheiner J, Meisel C, Goldammer M, Gerloff T, Kaiser R, Roots I. Pharmakogenetik als Basis neuer Therapiekonzepte. Bundesgesundheitsblatt 2003; 46: 835-844
14. Meisel C, Gerloff T, Kirchheiner J, Mrozikiewicz PM, Niewinski P, Brockmöller J, Roots I. Implications of pharmacogenetics for individualizing drug treatment and for study design. J Mol Med 2003; 81: 154-167
15. Merz JF, McGee GE, Sankar P. "Iceland Inc."?: On the ethics of commercial population genomics. Social Science and Medicine 2004; 58: 1201-1209
16. Tobin MD, Braund PS, Burton PR, Thompson JR, Steeds R, Channer K, Cheng S, Lindpaintner K, Samani NJ. Genotypes and haplotypes predisposing to myocardial infarction: a multilocus case-control study. European Heart Journal 2004; 25: 459-467
17. Tonisson N, Zernant J, Kurg A, Pavel H, Slavin G, Roomere H, Meiel A, Hainaut P, Metspalu A. Evaluating the arrayed primer extension resequencing assay of TP53 tumor suppressor gene. Proc Natl Acad Sci USA 2002; 99: 5503-5508